Overview

Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
We will compare between Carbitocin and Misoprostol in prevention of postpartum hemorrhage in high risk patients after C.S.
Phase:
Phase 4
Details
Lead Sponsor:
Beni-Suef University
Collaborator:
Cairo University
Treatments:
Carbetocin
Misoprostol
Oxytocin